LOCAL IMMUNITY AND METASTASIS OF COLORECTAL-CARCINOMA

被引:33
作者
KUBOTA, Y
SUNOUCHI, K
ONO, M
SAWADA, T
MUTO, T
机构
[1] First Department of Surgery, University of Tokyo School of Medicine, Tokyo
关键词
COLORECTAL CANCER; TUMOR-INFILTRATING LYMPHOCYTES; PROSTAGLANDIN-E2; METASTASIS; LOCAL IMMUNITY;
D O I
10.1007/BF02053754
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The subsets of tumor-infiltrating lymphocytes (TIL) and prostaglandin (PG) E2 were measured in the resected tissues of 32 colorectal cancers without metastasis and 14 with metastasis in order to investigate the local immunity in metastasis of colorectal carcinoma. Subsets of TIL (Leu 1, Leu 2a, Leu 3a, Leu 10, Leu 11b, IL-2 receptor) were detected by immunohistochemical staining of frozen tissues. The number of positive cells was counted and expressed as number positive per 250 X 250-mu-m2. The numbers of T cells (Leu 1) and natural killer cells (Leu 11b) were larger in early cancers and decreased in parallel with the presence of metastasis (control [n = 9]: 89 +/- 28, 6 +/- 4; early cancers [n = 9]: 269 +/- 112*, 76 +/- 56*; advanced cancers without metastasis [n = 111: 182 +/- 80*, 56 +/- 59*; advanced cancers with metastasis [n = 11]: 76 +/- 42*, 26 +/- 2 1; values are mean +/- SD; * P < 0.05, ANOVA). The level of PG E2 from the draining vein (V) measured by radioimmunoassay was higher than that from the feeding artery (A) (119.1 +/-14.3 vs. 15.4 +/- 1.9 pg/ml; P < 0.001). The PG E, V/A ratio of cancers with metastasis was significantly higher than that of those without metastasis (I 3.2 +/- 2.4 vs. 5.6 +/- 0.8; P < 0.001). TIL was decreased in parallel with the increase of PG E2 V/A ratio. We conclude that TIL and PG E2 may play an important role in metastasis of colorectal carcinoma and that PG E2 has an adverse effect in suppressing local immunity and enhancing metastasis.
引用
收藏
页码:645 / 650
页数:6
相关论文
共 35 条
[11]  
2-X
[12]   T-CELL SUBSETS AND LANGERHANS CELLS IN SKIN TUMORS [J].
FERNANDEZBUSSY, R ;
CAMBAZARD, F ;
MAUDUIT, G ;
SCHMITT, D ;
THIVOLET, J .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (07) :907-&
[13]   TUMOR-INFILTRATING LYMPHOCYTES - NEW THERAPY, NEW HOPES [J].
FIOCCHI, C ;
FINKE, JH .
GASTROENTEROLOGY, 1990, 98 (02) :531-534
[14]  
FISHER A, 1981, J IMMUNOL, V126, P1452
[15]  
FUJIMOTO S, 1976, J IMMUNOL, V116, P791
[16]  
FULTON AM, 1985, CANCER RES, V45, P4779
[17]  
GOLUB SH, 1974, CANCER RES, V34, P1833
[18]   SUPPRESSION OF HUMAN T-CELL MITOGENESIS BY PROSTAGLANDIN - EXISTENCE OF A PROSTAGLANDIN-PRODUCING SUPPRESSOR CELL [J].
GOODWIN, JS ;
BANKHURST, AD ;
MESSNER, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (06) :1719-1734
[19]  
GOODWIN JS, 1977, NEW ENGL J MED, V297, P963, DOI 10.1056/NEJM197711032971802
[20]   PROSTAGLANDINS AND CANCER - A REVIEW OF TUMOR INITIATION THROUGH TUMOR-METASTASIS [J].
HONN, KV ;
BOCKMAN, RS ;
MARNETT, LJ .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1981, 21 (05) :833-864